Synthesis, Molecular Docking and Preliminary Antileukemic Activity of 4‐Methoxybenzyl Derivatives Bearing Imidazo[2,1‐<i>b</i>][1,3,4]thiadiazole
B. Choodamani(Molina Center for Energy and the Environment), Subhas S. Karki(KLE University), Dominique Schols(Rega Institute for Medical Research), Ann Maria Tony(Amrita Institute of Medical Sciences and Research Centre), Austre Y. Schiaffino Bustamante(The University of Texas at El Paso), Karla Cano Hernandez(The University of Texas Southwestern Medical Center), Sujeet Kumar(KLE University), Renato J. Aguilera(The University of Texas at El Paso), C. Gopi Mohan(Amrita Institute of Medical Sciences and Research Centre)
Cited by 11
Related Papers
Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4
|FEBS Letters|2002|448
New Nitrogen Containing Substituents at the Indole-2-carboxamide Yield High Potent and Broad Spectrum Indolylarylsulfone HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
|Journal of Medicinal Chemistry|2012|61
Fluorescent CXCL12<sup>AF647</sup> as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies
|Cytometry Part A|2004|41
A molecular pathway for cancer cachexia-induced muscle atrophy revealed at single-nucleus resolution
|Cell Reports|2024|18
TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma
|Science Advances|2023|13